Maybaker (MAYBAKE)

Currency in NGN
19.500
+1.750(+9.86%)
Closed·
MAYBAKE Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Trading near 52-week High
MAYBAKE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.20019.500
52 wk Range
6.70019.500
Key Statistics
Bid/Ask
17.00 / 18.95
Prev. Close
17.75
Open
17.75
Day's Range
18.2-19.5
52 wk Range
6.7-19.5
Volume
2.81M
Average Volume (3m)
2.13M
1-Year Change
173.08%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MAYBAKE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.050
Downside
-33.08%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Maybaker News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Maybaker Company Profile

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products. It also provides beverage drinks, including bottled water under the Lily Water name; and hand and surface sanitizers under the Smartans name. In addition, the company engages in contract manufacturing of pharmaceutical products; and in healthcare and industrial packaging. May & Baker Nigeria Plc was incorporated in 1944 and is headquartered in Lagos, Nigeria.

Employees
392
Market
Nigeria

Compare MAYBAKE to Peers and Sector

Metrics to compare
MAYBAKE
Peers
Sector
Relationship
P/E Ratio
13.7x11.7x−0.5x
PEG Ratio
0.500.030.00
Price/Book
2.8x1.7x2.6x
Price / LTM Sales
0.9x1.7x3.3x
Upside (Analyst Target)
−26.5%1.3%42.8%
Fair Value Upside
Unlock12.0%6.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 13.050
(-33.08% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.36%
Dividend Yield
2.25%
Industry Median 2.19%
Annualised payout
0.40
Paid annually
5-Years Growth
+9.86%
Growth Streak

Earnings

Latest Release
Jul 28, 2025
EPS / Forecast
0.60 / --
Revenue / Forecast
9.78B / --
EPS Revisions
Last 90 days

MAYBAKE Income Statement

People Also Watch

3.980
CUTIX
+4.74%
38.00
ETERNAO
0.00%
81.90
VITAFOA
0.00%
43.05
CUSTODIAN
+9.96%
408.50
BETAGLA
0.00%

FAQ

What Stock Exchange Does Maybaker Trade On?

Maybaker is listed and trades on the Lagos stock exchange.

What Is the Stock Symbol for Maybaker?

The stock symbol for Maybaker is "MAYBAKE."

What Is the Maybaker Market Cap?

As of today, Maybaker market cap is 33.47B.

What Is Maybaker's Earnings Per Share (TTM)?

The Maybaker EPS (TTM) is 1.36.

From a Technical Analysis Perspective, Is MAYBAKE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Maybaker Stock Split?

Maybaker has split 3 times.

How Many Employees Does Maybaker Have?

Maybaker has 392 employees.

What is the current trading status of Maybaker (MAYBAKE)?

As of 06 Aug 2025, Maybaker (MAYBAKE) is trading at a price of 19.50, with a previous close of 17.75. The stock has fluctuated within a day range of 18.20 to 19.50, while its 52-week range spans from 6.70 to 19.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.